Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Hyperhidrosis, Inappropriate schedule of product administration, Influenza like illness, Injection site pruritus, Injection site warmth
Clinical narrative: Patch that also now burns / still / burns; One-inch band / that is itchy / it is still itchy; arm hot to touch / One-inche band / that is / hot to the touch /  it is still / hot to the touch; itchy red patch / Red patch grew to a three inch by three-inch; First Shingrix / October 26, 2020 / second Shingrix / on 6-8-21; Flu like symptoms; Muscle aches; Shivering; Sweating; GI symptoms; Slight headache; This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a 64-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 26th October 2020). Concomitant products included COVID-19 VACCINE (COVID 19 VACCINE) and COVID-19 VACCINE (COVID 19 VACCINE).   On 8th June 2021 08:00, the patient received the 2nd dose of Shingrix (intramuscular). On 8th June 2021, 5 hrs after receiving Shingrix, the patient experienced influenza-like symptoms, muscle pain, shivering, sweating, gastrointestinal disorder, headache and drug dose administration interval too long. On 9th June 2021, the patient experienced injection site itching, injection site warmth and skin red. On 10th June 2021, the patient experienced burning sensation. The patient was treated with paracetamol (Tylenol) and ibuprofen. On 10th June 2021, the outcome of the influenza-like symptoms, muscle pain, shivering, sweating, gastrointestinal disorder and headache were recovered/resolved. On an unknown date, the outcome of the injection site itching, injection site warmth, skin red and burning sensation were not recovered/not resolved and the outcome of the drug dose administration interval too long was unknown.   It was unknown if the reporter considered the influenza-like symptoms, muscle pain, shivering, sweating, gastrointestinal disorder, headache, injection site itching, injection site warmth, skin red and burning sensation to be related to Shingrix.  Additional details were provided as follows:  The patient had reported the case for herself. In April 2021 and May 2021, the patient received her Covid-19 vaccines in the left arm. The patient received 2nd dose of Shingrix in her left arm. The patient's health care professional advised her to wait until she received her Covid-19 vaccines before getting the second Shingrix vaccine, hence the patient received 2nd dose of Shingrix delayed than the recommended interval, which led to lengthening of the vaccination schedule. The patient experienced flu like symptoms, muscle aches, shivering, sweating, gastrointestinal symptoms (no details), and a slight headache, about 5 hours after receiving the second dose of Shingrix and those symptoms resolved in 2 days completely. The patient noticed a one-inch band just under the injection site that was itchy and hot to the touch and by Thursday, on 10th June 2021, the red patch grew to a three inch by three-inch red patch that also now burns. On the day of reportind, red patch had not gotten any bigger, but it was still itchy, hot to the touch and burns. The patient's daughter was an health care professional and advised her to take Tylenol alternating with Ibuprofen yesterday from the day of reporting and on the day of reporting.  She also suggested using hydrocortisone cream, but the patient has not gone to get that till the time of reporting. The reporter did not give permission to contact health care professional. The reporter did not consent to follow-up.